Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -18.51% | $ 666.87M | $ 123.43M |
3/31/2025 | -52.59% | $ 234.58M | $ 123.37M |
12/31/2024 | -30.03% | $ 410.86M | $ 123.37M |
9/30/2024 | -9.65% | $ 1.26B | $ 122.08M |
6/30/2024 | 0% | $ 700.23M | $ 34K |
3/31/2024 | -23.96% | $ 590.62M | $ 141.51M |
12/31/2023 | -29.27% | $ 531.56M | $ 155.59M |
9/30/2023 | -34.57% | $ 450M | $ 155.59M |
6/30/2023 | -20.21% | $ 891.53M | $ 180.17M |
3/31/2023 | -7.13% | $ 542.12M | $ 38.67M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for PHATHOM PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 191.47M ]) / Market Cap [ $ 1.2B ]
(=) Buyback Yield [ -15.93% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |